Adverse Event Reports: Posting On ClinicalTrials.gov Begins Soon
This article was originally published in The Gray Sheet
Executive Summary
Device and drug firms must begin posting serious and frequent adverse event data from certain clinical trials on the National Institutes of Health's ClinicalTrials.gov database by September, NIH confirmed April 20
You may also be interested in...
ClinicalTrials.gov: NIH Busy Educating Sponsors On Mandates While Regs Remain In The Works
Draft rules are still being developed to fully implement ClinicalTrials.gov, but the law has been in effect for some time and officials say they are making a consistent effort to ensure study sponsors are educated on their new responsibilities.
ClinicalTrials.gov: NIH Busy Educating Sponsors On Mandates While Regs Remain In The Works
Draft rules are still being developed to fully implement ClinicalTrials.gov, but the law has been in effect for some time and officials say they are making a consistent effort to ensure study sponsors are educated on their new responsibilities.
Regs Or No Regs, FDA Will Seek Adherence To ClinicalTrials.gov Mandates
Manufacturer confusion over ClinicalTrials.gov trial registration and reporting requirements is no excuse for failing to make a good-faith attempt at compliance, FDA and NIH officials say